A detailed history of Eagle Global Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Eagle Global Advisors LLC holds 109,813 shares of NVO stock, worth $9.59 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
109,813
Previous 110,598 0.71%
Holding current value
$9.59 Million
Previous $15.8 Million 17.17%
% of portfolio
0.67%
Previous 0.85%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $93,469 - $114,154
-785 Reduced 0.71%
109,813 $13.1 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $154,491 - $184,959
-1,259 Reduced 1.13%
110,598 $15.8 Million
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $1.42 Million - $1.88 Million
-13,858 Reduced 11.02%
111,857 $14.4 Million
Q4 2023

Feb 09, 2024

SELL
$87.78 - $105.45 $21,067 - $25,308
-240 Reduced 0.19%
125,715 $13 Million
Q3 2023

Oct 30, 2023

BUY
$90.94 - $199.54 $5.7 Million - $12.5 Million
62,713 Added 99.16%
125,955 $11.5 Million
Q2 2023

Jul 21, 2023

SELL
$155.98 - $172.65 $505,375 - $559,386
-3,240 Reduced 4.87%
63,242 $10.2 Million
Q1 2023

May 08, 2023

SELL
$132.34 - $159.14 $1.91 Million - $2.3 Million
-14,434 Reduced 17.84%
66,482 $10.6 Million
Q4 2022

Feb 07, 2023

SELL
$102.55 - $135.33 $108,908 - $143,720
-1,062 Reduced 1.3%
80,916 $11 Million
Q3 2022

Oct 24, 2022

SELL
$95.28 - $116.93 $90,039 - $110,498
-945 Reduced 1.14%
81,978 $8.17 Million
Q2 2022

Aug 11, 2022

SELL
$103.24 - $121.81 $42,225 - $49,820
-409 Reduced 0.49%
82,923 $9.24 Million
Q1 2022

Apr 20, 2022

BUY
$93.1 - $112.54 $19,085 - $23,070
205 Added 0.25%
83,332 $9.25 Million
Q4 2021

Feb 01, 2022

BUY
$95.88 - $117.08 $13,902 - $16,976
145 Added 0.17%
83,127 $9.31 Million
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $7,597 - $9,595
-90 Reduced 0.11%
82,982 $7.97 Million
Q2 2021

Jul 15, 2021

BUY
$67.66 - $84.76 $107,579 - $134,768
1,590 Added 1.95%
83,072 $6.96 Million
Q1 2021

May 07, 2021

SELL
$67.06 - $75.82 $190,919 - $215,859
-2,847 Reduced 3.38%
81,482 $5.49 Million
Q4 2020

Feb 01, 2021

SELL
$63.89 - $73.8 $8,305 - $9,594
-130 Reduced 0.15%
84,329 $5.89 Million
Q3 2020

Oct 22, 2020

SELL
$63.69 - $70.22 $60,441 - $66,638
-949 Reduced 1.11%
84,459 $5.86 Million
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $151,267 - $175,556
-2,584 Reduced 2.94%
85,408 $5.59 Million
Q1 2020

May 06, 2020

SELL
$49.46 - $64.78 $234,193 - $306,733
-4,735 Reduced 5.11%
87,992 $5.3 Million
Q4 2019

Feb 06, 2020

SELL
$49.86 - $58.26 $45,871 - $53,599
-920 Reduced 0.98%
92,727 $5.37 Million
Q3 2019

Nov 14, 2019

SELL
$47.54 - $53.43 $458,998 - $515,866
-9,655 Reduced 9.35%
93,647 $4.84 Million
Q2 2019

Aug 13, 2019

SELL
$46.79 - $52.47 $862,526 - $967,231
-18,434 Reduced 15.14%
103,302 $5.27 Million
Q1 2019

Apr 22, 2019

BUY
$46.36 - $52.63 $26,286 - $29,841
567 Added 0.47%
121,736 $6.37 Million
Q4 2018

Jan 30, 2019

SELL
$41.54 - $47.25 $452,578 - $514,788
-10,895 Reduced 8.25%
121,169 $5.58 Million
Q3 2018

Nov 14, 2018

SELL
$46.76 - $51.24 $153,372 - $168,067
-3,280 Reduced 2.42%
132,064 $6.23 Million
Q2 2018

Aug 01, 2018

BUY
$44.29 - $50.42 $218,083 - $248,268
4,924 Added 3.78%
135,344 $6.24 Million
Q1 2018

May 04, 2018

SELL
$48.49 - $58.14 $754,019 - $904,077
-15,550 Reduced 10.65%
130,420 $6.42 Million
Q4 2017

Feb 13, 2018

BUY
$47.53 - $53.73 $62,026 - $70,117
1,305 Added 0.9%
145,970 $7.83 Million
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $5.95 Million - $7.12 Million
144,665
144,665 $6.97 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Eagle Global Advisors LLC Portfolio

Follow Eagle Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Global Advisors LLC with notifications on news.